CARERATING · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
CARE Ratings reported strong FY26 results with standalone revenue growing 15% to Rs. 387.72 Crores and consolidated revenue up 18% to Rs. 473.07 Crores. Standalone EBITDA improved 21% to Rs. 187.39 Crores with margin expanding to 48%, while consolidated PAT rose 24% to Rs. 173.69 Crores. Q4 standalone revenue was Rs. 107.58 Crores (18% YOY) with EBITDA margin at 54%. The ratings segment contributed Rs. 423.05 Crores (17% growth, 89% of revenue) while non-ratings grew 19% to Rs. 50.01 Crores. SEBI-launched PaRRVA agency debuted commercially in April 2026. The company deployed AI tools across operations with 60% staff actively using them. The board recommended a final dividend of Rs. 14 per share (total Rs. 22 per share). Management flagged macro headwinds from West Asia conflict, elevated oil prices, and projected FY27 GDP growth at 6.7%.
CARE Ratings delivered robust growth with margin expansion driven by operating leverage and diversification into non-ratings businesses. Strong cash generation supports the dividend. Macro headwinds from geopolitical tensions and potential monsoon weakness could impact fund-raising activity, a key revenue driver for the ratings business.